We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Collaboration to Advance Hematology Diagnostics

By HospiMedica staff writers
Posted on 04 Feb 2004
An alliance to develop new, clinically important hematology diagnostics has been announced by Bio-Reference Laboratories, Inc. More...
(Elmwood Park, NJ, USA) and Sysmex America, Inc. (Mundelein, IL, USA).

Bio-Reference is a large, independent regional clinical laboratory in the northeastern U.S. with a specialized cancer pathology and molecular diagnostics unit called GenPath. Sysmex is a leading diagnostic instrument manufacturer and information systems developer. Bio-Reference believes that Sysmex's innovation and technical superiority can help the company identify and validate new hematology diagnostics. Sysmex was the first company to develop an approved automated measurement of immature granulocytes, the first to automate nucleated red blood cells, using fluorescent flow cytometry, and the first to bring the diode laser to hematology.

"Sysmex America's innovation and technical superiority have resulted in a ‘best of breed' philosophy that has produced a hematology product offering known for its high quality and the introduction of clinically important new parameters,” said Marc D. Grodman, M.D., president and CEO of Bio-Reference Labs. "This is the type of partner that Bio-Reference Laboratories seeks in order to provide its physician-customers with competitive, world-class diagnostics.”




Related Links:
Bio-Reference
Sysmex

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
HPV Test
Allplex HPV28 Detection
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.